First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background: Malaria in pregnancy has major impacts on mother and child health. To complement existing interventions, such as intermittent preventive treatment and use of impregnated bed nets, we developed a malaria vaccine candidate with the aim of reducing sequestration of asexual “blood-stage” parasites in the placenta, the major virulence mechanism. Methods: The vaccine candidate PAMVAC is based on a recombinant fragment of VAR2CSA, the Plasmodium falciparum protein responsible for binding to the placenta via chondroitin sulfate A (CSA). Healthy, adult malaria-naive volunteers were immunized with 3 intramuscular injections of 20 μg (n = 9) or 50 μg (n = 27) PAMVAC, adjuvanted with Alhydrogel or glucopyranosyl lipid adjuvant in stable emulsion (GLA-SE) or in a liposomal formulation with QS21 (GLA-LSQ). Allocation was random and double blind. The vaccine was given every 4 weeks. Volunteers were observed for 6 months following last immunization. Results: All PAMVAC formulations were safe and well tolerated. A total of 262 adverse events (AEs) occurred, 94 (10 grade 2 and 2 grade 3) at least possibly related to the vaccine. No serious AEs occurred. Distribution and severity of AEs were similar in all arms. PAMVAC was immunogenic in all participants. PAMVAC-specific antibody levels were highest with PAMVAC-GLA-SE. The antibodies inhibited binding of VAR2CSA expressing P. falciparum-infected erythrocytes to CSA in a standardized functional assay. Conclusions: PAMVAC formulated with Alhydrogel or GLA-based adjuvants was safe, well tolerated, and induced functionally active antibodies. Next, PAMVAC will be assessed in women before first pregnancies in an endemic area. Clinical Trials Registration: EudraCT 2015-001827-21; ClinicalTrials.gov NCT02647489.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two VAR2CSA N-terminal subunits containing the minimal CSA-binding fragment [5] have been tested in Phase I clinical trials [6,7] but did not induce strain-transcending neutralizing immunoglobulin G (IgG).”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antibody to PAM1.4-like strain-transcending epitopes may fail to be induced by VAR2CSA subunit immunogens (Fig 1D), as seen in humans immunized with VAR2CSA fragments who mounted limited serum functional activity against heterologous strains [6,7].”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenic basis of malaria
Miller, L. H., Baruch, D. I., Marsh, K., & Doumbo, O. K. (2002) · Nature · doi:10.1038/415673a · Cited by 1,746
Su, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Baruch, D. I., Pasloske, B. L., Singh, H. B., Bi, X., Ma, X. C., Feldman, M., Taraschi, T. F., & Howard, R. J. (1995) · Cell · doi:10.1016/0092-8674(95)90054-3 · Cited by 1,030
Self-citationSalanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702 · cited 1×
“1510 • cid 2019:69 (1 November) • Mordmüller et al form of chondroitin sulfate A (CSA) [8].”
BackgroundSelf-citationMaternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659
Bull, P. C., Lowe, B. S., Kortok, M., Molyneux, C. S., Newbold, C. I., & Marsh, K. (1998) · Nature Medicine · doi:10.1038/nm0398-358 · Cited by 645
Malaria in pregnancy: pathogenesis and immunity
Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F., & Taylor, D. W. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70022-1 · Cited by 628
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604
Self-citationAntigens Induced on Erythrocytes by P. falciparum : Expression of Diverse and Conserved Determinants
Marsh, K., & Howard, R. J. (1986) · Science · doi:10.1126/science.2417315 · Cited by 322
Self-citationRicke, C. H., Staalsoe, T., Koram, K., Akanmori, B. D., Riley, E. M., Theander, T. G., & Hviid, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3309 · Cited by 303
Self-citation
Cited by
Frederiksen, L. S. F., Zhang, Y., Foged, C., & Thakur, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01817 · Cited by 287
Malaria vaccines since 2000: progress, priorities, products
Duffy, P. E., & Patrick Gorres, J. (2020) · npj Vaccines · doi:10.1038/s41541-020-0196-3 · Cited by 266
New insights into malaria pathogenesis
Moxon, C. A., Gibbins, M. P., McGuinness, D., Milner, D. A., & Marti, M. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032640 · Cited by 207
“The unique conservation of this PfEMP1 variant, its specific function, and the existence of natural protective immunity make VAR2CSA a prime candidate for a malaria subunit vaccine (146, 147).”
BackgroundJensen, A. R., Adams, Y., & Hviid, L. (2020) · Immunological Reviews · doi:10.1111/imr.12807 · Cited by 158
Malaria vaccines: a new era of prevention and control
Duffy, P. E., Gorres, J. P., Healy, S. A., & Fried, M. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01065-7 · Cited by 143
The continued advance of vaccine adjuvants – ‘we can work it out’
O’Hagan, D. T., Lodaya, R. N., & Lofano, G. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101426 · Cited by 127
Sirima, S. B., Richert, L., Chêne, A., Konate, A. T., Campion, C., Dechavanne, S., Semblat, J.-P., Benhamouda, N., Bahuaud, M., Loulergue, P., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30739-x · Cited by 124
Self-citationChua, C. L. L., Hasang, W., Rogerson, S. J., & Teo, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621382 · Cited by 113
Malaria Vaccines: Progress to Date
Stanisic, D. I., & Good, M. F. (2023) · BioDrugs · doi:10.1007/s40259-023-00623-4 · Cited by 96
Current Status of COVID‐19 (Pre)Clinical Vaccine Development
Ye, T., Zhong, Z., García‐Sastre, A., Schotsaert, M., & Geest, B. G. D. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202008319 · Cited by 80
Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA.
Ma, R., Lian, T., Huang, R., Renn, J. P., Petersen, J. D., Zimmerberg, J., Duffy, P. E., & Tolia, N. H. (2021) · Nature Microbiology · doi:10.1038/s41564-020-00858-9 · Cited by 72
Zakama, A. K., Ozarslan, N., & Gaw, S. L. (2020) · Current Tropical Medicine Reports · doi:10.1007/s40475-020-00213-2 · Cited by 72
Pathogenicity and virulence of malaria: Sticky problems and tricky solutions
Walker, I. S., & Rogerson, S. J. (2023) · Virulence · doi:10.1080/21505594.2022.2150456 · Cited by 70
Larsen, M. D., Lopez-Perez, M., Dickson, E. K., Ampomah, P., Ndam, N. T., Nouta, J., Koeleman, C. A. M., Ederveen, A. L. H., Mordmüller, B. G., Salanti, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26118-w · Cited by 67
Self-citationSaito, M., Briand, V., Min, A. M., & McGready, R. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30099-7 · Cited by 61
Current approaches to malaria vaccines
Duffy, P. E. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102227 · Cited by 58
Wang, K., Dagil, R., Lavstsen, T., Misra, S. K., Spliid, C. B., Wang, Y., Gustavsson, T., Sandoval, D. R., Vidal-Calvo, E. E., Choudhary, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23254-1 · Cited by 52
Self-citationAitken, E. H., Damelang, T., Ortega-Pajares, A., Alemu, A., Hasang, W., Dini, S., Unger, H. W., Ome‐Kaius, M., Nielsen, M. A., Salanti, A., et al. (2021) · eLife · doi:10.7554/elife.65776 · Cited by 50
Self-citationSmit, M. J., Sander, A. F., Ariaans, M. B. P. A., Fougeroux, C. E., Heinzel, C., Fendel, R., Esen, M., Kremsner, P. G., ter Heine, R., Wertheim, H. F. L., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00337-8 · Cited by 50
Self-citationProgress and Insights Toward an Effective Placental Malaria Vaccine
Gamain, B., Chêne, A., Viebig, N. K., Ndam, N. T., & Nielsen, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.634508 · Cited by 46
Self-citationDiawara, H., Healy, S. A., Mwakingwe-Omari, A., Issiaka, D., Diallo, A., Traore, S., Soumbounou, I. H., Gaoussou, S., Zaidi, I., Mahamar, A., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00360-8 · Cited by 43
Vector-borne diseases in pregnancy
O’Kelly, B., & Lambert, J. S. (2020) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936120941725 · Cited by 42
Correlates of malaria vaccine efficacy
Stanisic, D. I., & McCall, M. B. B. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1882309 · Cited by 41
Multi-functional antibody profiling for malaria vaccine development and evaluation
Opi, D. H., Kurtovic, L., Chan, J.-A., Horton, J. L., Feng, G., & Beeson, J. G. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1981864 · Cited by 41
Advances in vaccine adjuvant development and future perspectives
Sinani, G., & Şenel, S. (2025) · Drug Delivery · doi:10.1080/10717544.2025.2517137 · Cited by 41
Tomlinson, A., Semblat, J., Gamain, B., & Chêne, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.624126 · Cited by 39
Figueroa-Romero, A., Pons‐Duran, C., & González, R. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7080152 · Cited by 38
Vaccines and monoclonal antibodies: new tools for malaria control
Miura, K., Flores-García, Y., Long, C. A., & Zavala, F. P. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00071-23 · Cited by 38
Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC
Chêne, A., Gangnard, S., Guadall, A., Ginisty, H., Leroy, O. Y., Havelange, N., Viebig, N. K., & Gamain, B. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.010 · Cited by 36
Self-citationBaldwin, S. L., Reese, V. A., Larsen, S. E., Beebe, E. A., Guderian, J. A., Orr, M. T., Fox, C. B., Reed, S. G., & Coler, R. N. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247990 · Cited by 36
Self-citationSingh, S. K., Plieskatt, J. L., Chourasia, B. K., Fabra-García, A., Garcia-Senosiain, A., Singh, V., Bengtsson, K. L., Reimer, J. M., Sauerwein, R. W., Jore, M. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.606266 · Cited by 35
Ramharter, M., Agnandji, S. T., Adégnika, A. A., Lell, B., Mombo‐Ngoma, G., Grobusch, M. P., McCall, M. B. B., Muranaka, R., Kreidenweiss, A., Velavan, T. P., et al. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01794-8 · Cited by 34
Self-citationCombining malaria vaccination with chemoprevention: a promising new approach to malaria control.
Greenwood, B., Cairns, M., Chaponda, M., Chico, R. M., Dicko, A., Ouedraogo, J.-B., Phiri, K. S., ter Kuile, F. O., & Chandramohan, D. (2021) · Malaria Journal · doi:10.1186/s12936-021-03888-8 · Cited by 32
Malaria in pregnancy: adverse pregnancy outcomes and the future of prevention
Berhe, A. D., Doritchamou, J. Y. A., & Duffy, P. E. (2023) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2023.1229735 · Cited by 30
Unveiling the Sugary Secrets of Plasmodium Parasites
Goerdeler, F., Seeberger, P. H., & Moscovitz, O. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.712538 · Cited by 29
Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers
Sliepen, K., Schermer, E. E., Bontjer, I., Burger, J. A., Lévai, R. F., Mundsperger, P., Brouwer, P. J. M., Tolazzi, M., Farsang, A., Katinger, D., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00364-x · Cited by 29
Antibody mediated activation of natural killer cells in malaria exposed pregnant women
Damelang, T., Aitken, E. H., Hasang, W., López, E., Killian, M., Unger, H. W., Salanti, A., Shub, A., McCarthy, E. A., Kedzierska, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83093-4 · Cited by 27
Self-citationHviid, L., Jensen, A. T. R., & Deitsch, K. (2024) · Advances in Parasitology/Advances in parasitology · doi:10.1016/bs.apar.2024.02.001 · Cited by 26
Comprehensive Overview of Vaccination during Pregnancy in Europe
SIMIONESCU, A. A., Streinu‐Cercel, A., Popescu, F., Stănescu, A. M. A., Vieru, M., Danciu, B. M., Miron, V. D., & Săndulescu, O. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111196 · Cited by 26
Recent clinical trials inform the future for malaria vaccines
Kurtovic, L., Reiling, L., Opi, D. H., & Beeson, J. G. (2021) · Communications Medicine · doi:10.1038/s43856-021-00030-2 · Cited by 26
Recent perspectives in clinical development of malaria vaccines
Feehan, J., Plebanski, M., & Apostolopoulos, V. (2025) · Nature Communications · doi:10.1038/s41467-025-58963-4 · Cited by 25
Renn, J. P., Doritchamou, J. Y. A., Tentokam, B. C. N., Morrison, R. D., Cowles, M. V., Burkhardt, M., Ma, R., Mahamar, A., Attaher, O., Diarra, B. S., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02787-7 · Cited by 24
Boltena, M. T., El‐Khatib, Z., Kebede, A. S., Asamoah, B. O., Appiah, S. C. Y., Kamara, K., Assogba, P., Boltena, A. T., Taye, H., Hailemeskel, E., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095444 · Cited by 26
Re-orienting anti-malarial drug development to better serve pregnant women
Gaaloul, M. E., Tornesi, B. M., Lebus, F., Reddy, D., & Kaszubska, W. (2022) · Malaria Journal · doi:10.1186/s12936-022-04137-2 · Cited by 24
Doritchamou, J. Y., Renn, J. P., Jenkins, B., Mahamar, A., Dicko, A., Fried, M., & Duffy, P. E. (2022) · eLife · doi:10.7554/elife.76264 · Cited by 23
Opi, D. H., Boyle, M. J., McLean, A. R. D., Reiling, L., Chan, J.-A., Stanisic, D. I., Ura, A., Müeller, I., Fowkes, F. J. I., Rogerson, S. J., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02061-x · Cited by 23
Mitran, C. J., Mena, A., Gnidehou, S., Banman, S. L., Arango, E., Lima, B. A. S., Lugo, H., Ganesan, A., Salanti, A., Mbonye, A. K., et al. (2019) · mBio · doi:10.1128/mbio.02343-19 · Cited by 23
Self-citationFriedman-Klabanoff, D. J., Berry, A. A., Travassos, M. A., Cox, C., Zhou, Y., Mo, A. X. Y., Nomicos, E. Y. H., Deye, G. A., Pasetti, M. F., & Laurens, M. B. (2021) · Vaccine · doi:10.1016/j.vaccine.2020.12.023 · Cited by 22
Malaria vaccines: facing unknowns
Palacpac, N., & Horii, T. (2020) · F1000Research · doi:10.12688/f1000research.22143.1 · Cited by 22
Progress and new horizons toward a VAR2CSA-based placental malaria vaccine
Doritchamou, J., Suurbaar, J., & Ndam, N. T. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1878029 · Cited by 21
Self-citationStochastic expression of invasion genes in Plasmodium falciparum schizonts
Tripathi, J., Zhu, L., Nayak, S., Stoklasa, M., & Bozdech, Z. (2022) · Nature Communications · doi:10.1038/s41467-022-30605-z · Cited by 21
No sweet deal: the antibody-mediated immune response to malaria
Hviid, L., Lopez-Perez, M., Larsen, M. D., & Vidarsson, G. (2022) · Trends in Parasitology · doi:10.1016/j.pt.2022.02.008 · Cited by 20
Qi, Y., & Fox, C. B. (2020) · Journal of Chromatography A · doi:10.1016/j.chroma.2020.461705 · Cited by 20
Vress, D. (2021) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2021.03.009 · Cited by 19
Wang, W., Wang, Z., Yang, X., Gao, Y., Zhang, X., Wang, W., Zhao, L., zhang, J., Jing, Q., Xu, Q., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00324-8 · Cited by 19
A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development
Pirahmadi, S., Zakeri, S., Djadid, N. D., & Mehrizi, A. A. (2021) · International Journal for Parasitology · doi:10.1016/j.ijpara.2021.01.006 · Cited by 19
Empfehlungen zur Malariaprophylaxe
Rothe, C., Rosenbusch, D., Alberer, M., Bühler, S., Burchard, G. D., Erkens, K., Feldt, T., Grobusch, M. P., Köhler, C., Kapaun, A., et al. (2021) · Flugmedizin · Tropenmedizin · Reisemedizin - FTR · doi:10.1055/a-1520-3764 · Cited by 18
Pregnancy and malaria: The perfect storm
Rogerson, S. J., & Unger, H. W. (2022) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000859 · Cited by 17
“The vaccines incorporated sequences from the VAR2CSA protein implicated in placental binding [25,26].”
BackgroundPregnancy outcomes in a malaria-exposed Malian cohort of women of child-bearing age
Gaoussou, S., Attaher, O., Swihart, B., Traoré, M., Diarra, S., Soumbounou, I. H., Ndiaye, O., Issiaka, D., Morrison, R., Mahamar, A., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1061538 · Cited by 15
Tornyigah, B., d’Almeida, T. C., Escriou, G., Viwami, F., Fiévet, N., Luty, A. J. F., Massougbodji, A., Nielsen, M. A., Deloron, P., & Ndam, N. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.610305 · Cited by 15
Self-citationRaghavan, S. S. R., Dagil, R., Lopez-Perez, M., Conrad, J., Bassi, M. R., Quintana, M. D. P., Choudhary, S., Gustavsson, T., Wang, Y., Gourdon, P., et al. (2022) · PLOS Pathogens · doi:10.1371/journal.ppat.1010924 · Cited by 14
“However, these vaccine candidates induced only low titres of antibodies and very limited cross-reactivity in human phase I clinical trials [11, 24, 25].”
Self-citationMeeting report: WHO consultation on malaria vaccine development, Geneva, 15–16 July 2019
Vekemans, J., Schellenberg, D. M., Benns, S., O’Brien, K. L., & Alonso, P. L. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.03.093 · Cited by 14
Red Blood Cells Oligosaccharides as Targets for Plasmodium Invasion
Burzyńska, P., Jodłowska, M., Zerka, A., Czujkowski, J., & Jaśkiewicz, E. (2022) · Biomolecules · doi:10.3390/biom12111669 · Cited by 14
Otterdal, K., Berg, Å., Michelsen, A. E., Patel, S., Gregersen, I., Sagen, E. L., Halvorsen, B. L., Yndestad, A., Ueland, T., Langeland, N., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4783-8 · Cited by 14
McLean, A. R. D., Opi, D. H., Stanisic, D. I., Cutts, J. C., Feng, G., Ura, A., Müeller, I., Rogerson, S. J., Beeson, J. G., & Fowkes, F. J. I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.644563 · Cited by 13
How can we develop an effective subunit vaccine to achieve successful malaria eradication?
Pirahmadi, S., Afzali, S., Zargar, M., Zakeri, S., & Mehrizi, A. A. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105203 · Cited by 13
Ma, R., Salinas, N. D., Orr-Gonzalez, S., Richardson, B., Ouahes, T., Torano, H., Jenkins, B. J., Dickey, T. H., Neal, J., Duan, J., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011879 · Cited by 12
Mitran, C. J., Higa, L. M., Good, M. F., & Yanow, S. K. (2020) · Vaccines · doi:10.3390/vaccines8030392 · Cited by 11
Adverse pregnancy outcomes among women presenting at antenatal clinics in Ouélessébougou, Mali
Andemel, N., Gaoussou, S., Barry, A., Issiaka, D., Mahamar, A., Traoré, M., Duffy, P. E., Dicko, A., & Fried, M. (2020) · Reproductive Health · doi:10.1186/s12978-020-0890-7 · Cited by 11
Lopez-Perez, M., Seidu, Z., Larsen, M. D., Wang, W., Nouta, J., Wuhrer, M., Vidarsson, G., Ofori, M. F., & Hviid, L. (2025) · Nature Communications · doi:10.1038/s41467-024-55543-w · Cited by 11
Swart, M., Kuipers, H., Milder, F. J., Jongeneelen, M. A. C., Ritschel, T., Tolboom, J. T. B. M., Muchene, L. K., van der Lubbe, J. E. M., Gil, A. I., Veldman, D., et al. (2023) · npj Vaccines · doi:10.1038/s41541-023-00772-1 · Cited by 11
Takashima, E., Nagaoka, H., Correia, R., Alves, P. M., Roldão, A., Christensen, D., Guderian, J. A., Fukushima, A., Viebig, N. K., Depraetere, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1002430 · Cited by 10
Empfehlungen zur Malariaprophylaxe
Rothe, C., Rosenbusch, D., Alberer, M., Bühler, S., Burchard, G. D., Erkens, K., Feldt, T., Grobusch, M. P., Köhler, C., Kapaun, A., et al. (2020) · Flugmedizin · Tropenmedizin · Reisemedizin - FTR · doi:10.1055/a-1204-1496 · Cited by 10
Lopez-Perez, M., Viwami, F., Ampomah, P., Šuštić, T., Larsen, M. D., Wuhrer, M., Vidarsson, G., Ofori, M. F., Ndam, N. T., & Hviid, L. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae529 · Cited by 9
Self-citationCurrent Status of COVID‐19 (Pre)Clinical Vaccine Development
Ye, T., Zhong, Z., García‐Sastre, A., Schotsaert, M., & Geest, B. G. D. (2020) · Angewandte Chemie · doi:10.1002/ange.202008319 · Cited by 9
Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors
Khazamipour, N., Oo, H. Z., Al-Nakouzi, N., Marzban, M., Khazamipour, N., Roberts, M. E., Farivar, N., Moskalev, I., Lo, J., Ghaidi, F., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00153-8 · Cited by 9
Self-citationA Malária no Período Gestacional: Uma Revisão
Moraes, G. F. Q., Lopes, T. M. S., Maurício, F. D., Santos, T. L. B., & Júnior, F. P. D. A. (2020) · Almanaque Multidisciplinar de Pesquisa · Cited by 9
A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?
Doritchamou, J. Y. A., Renn, J. P., Hviid, L., & Duffy, P. E. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011370 · Cited by 8
“4-like strain-transcending epitopes may fail to be induced by VAR2CSA subunit immunogens (Fig 1D), as seen in humans immunized with VAR2CSA fragments who mounted limited serum functional activity against heterologous strains [6,7].”
BackgroundMenon, S., D’Alessio, F., Chaudhuri, N., Onwuchekwa, C., Kaur, M., Nkumama, I. N., & Olesen, O. F. (2025) · Journal of Global Health · doi:10.7189/jogh.15.04355 · Cited by 8
VAR2CSA Antibodies in Non-Pregnant Populations
Gnidehou, S., & Yanow, S. K. (2020) · Trends in Parasitology · doi:10.1016/j.pt.2020.09.012 · Cited by 8
Jagadeeshaprasad, M. G., Gautam, L., Bewley, M. C., Goel, S., Akhouri, R. R., & Gowda, D. C. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.258 · Cited by 8
Eacret, J. S., Parzych, E. M., Gonzales, D. M., & Burns, J. M. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000927 · Cited by 8
Iyamu, U., Vinals, D. F., Tornyigah, B., Arango, E., Bhat, R., Adra, T. R., Grewal, S., Martin, K., Maestre, A., Overduin, M., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1202276 · Cited by 7
The glycobiology of plasmodium falciparum: New approaches and recent advances
Izquierdo, L. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108178 · Cited by 7
Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine
Good, M. F., & Yanow, S. K. (2023) · Trends in Parasitology · doi:10.1016/j.pt.2023.08.006 · Cited by 7
Empfehlungen zur Malariaprophylaxe
Rothe, C., Boecken, G., Rosenbusch, D., Alberer, M., Bühler, S., Burchard, G. D., Erkens, K., Feldt, T., Grobusch, M. P., Köhler, C., et al. (2019) · Flugmedizin · Tropenmedizin · Reisemedizin - FTR · doi:10.1055/a-0916-5128 · Cited by 7
Empfehlungen zur Malariaprophylaxe
Rothe, C., Rosenbusch, D., Alberer, M., Bühler, S., Burchard, G. D., Feldt, T., Grobusch, M. P., Köhler, C., Kapaun, A., Kreuzberg, C., et al. (2022) · Flugmedizin · Tropenmedizin · Reisemedizin - FTR · doi:10.1055/a-1919-2660 · Cited by 7
Entwicklung von Impfstoffen gegen Malaria – aktueller Stand
Metzger, W. G., Sulyok, Z., Theurer, A., & Köhler, C. (2019) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-019-03070-1 · Cited by 6
Malaria, Urogenital Schistosomiasis, and Anaemia in Pregnant Ghanaian Women
Frempong, N. A., Ahiabor, C., Anyan, W. K., Mama, A., Kusi, K. A., Ofori, M. F., Adu, B., Debrah, A. Y., Anang, A. K., Ndam, N. T., et al. (2023) · Journal of Parasitology Research · doi:10.1155/2023/7500676 · Cited by 6
Self-citationImmune Responses in Malaria and Vaccine Strategies
Ferluga, J., Singh, I., Rout, S., Al-Qahtani, A. A., Yasmin, H., & Kishore, U. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-67452-6_12 · Cited by 6
Rotich, A. K., Takashima, E., Yanow, S. K., Gitaka, J., & Kanoi, B. N. (2022) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2022.988284 · Cited by 5
New Strides in Prevention of Malaria during Pregnancy Present Multitudinous Opportunities
Gill, J., & Anvikar, A. R. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00566 · Cited by 5
Development of a process for large scale production of PfRH5 in E. coli expression system
Raghuwanshi, A. S., Kumar, A., Raghuwanshi, N., Singh, S. K., Singh, A. K., Tripathi, U., Kaviraj, S., & Singh, S. P. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.08.014 · Cited by 5
Advances in the development of malaria vaccines
Sorgho, H., Rouamba, T., Natama, H. M., & Tinto, H. (2026) · BMJ · doi:10.1136/bmj-2025-084166 · Cited by 5
The Evolving Maternal Vaccine Platform
Adams, R. M., & Gonik, B. (2024) · Reproductive Medicine · doi:10.3390/reprodmed5030014 · Cited by 4
Doritchamou, J., Nielsen, M. A., Chêne, A., Viebig, N. K., Lambert, L., Sander, A. F., Semblat, J., Hundt, S., Orr-Gonzalez, S., Janitzek, C. M., et al. (2023) · Lab Animal · doi:10.1038/s41684-023-01274-2 · Cited by 4
Self-citationMalaria in Pregnancy, Current Challenges, and Emerging Prevention Strategies in a Warming Climate
Ranjit, A., & Wylie, B. J. (2024) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000888 · Cited by 4
Talundzic, E., Scott, S., Owino, S. O., Campo, D. S., Lucchi, N. W., Udhayakumar, V., Moore, J. M., & Peterson, D. S. (2022) · Pathogens · doi:10.3390/pathogens11050520 · Cited by 4
Potential pharmacologic interventions targeting TLR signaling in placental malaria
Kobia, F., Maiti, K., Obimbo, M., Smith, R., & Gitaka, J. (2022) · Trends in Parasitology · doi:10.1016/j.pt.2022.04.002 · Cited by 4
Malaria Vaccine Development and Associated Challenges
Adukpo, S. (2024) · Infectious diseases · doi:10.5772/intechopen.115131 · Cited by 4
Metadata
- Authors
- Mordmüller, B., Sulyok, M., Egger-Adam, D., Resende, M., de Jongh, W. A., Jensen, M. H., Smedegaard, H. H., Ditlev, S. B., Soegaard, M., Poulsen, L., Dyring, C., Calle, C. L., Knoblich, A., Ibáñez, J., Esen, M., Deloron, P., Ndam, N., Issifou, S., Houard, S., Howard, R. F., Reed, S. G., Leroy, O., Luty, A. J. F., Theander, T. G., Kremsner, P. G., Salanti, A., & Nielsen, M. A.
- Affiliations
- Universitätsklinikum Tübingen (DE)
- Institut für Tropenmedizin, Universitätsklinikum Tübingen and Deutsches Zentrum für Infektionsforschung, Germany
- University of Copenhagen (DK)
- ExpreS2ion Biotechnologies, Horsholm, Denmark
- Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Copenhagen University Hospital
- ExpreS2ion Biotechnologies (Denmark) (DK)
- Sorbonne Paris Cité (FR)
- Institut de Recherche Clinique du Bénin (BJ)
- European Vaccine Initiative (DE)
- Infectious Disease Research Institute (US)
- Corresponding author
- Nielsen, Morten A
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-10
- Volume
- 69
- Issue
- 9
- Pages
- 1509-1516
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC6792113
- OpenAlex
- W2910623818
- Cited by
- 154
- References
- 39
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 21 · 2023: 17 · 2022: 27 · 2021: 38 · 2020: 21 · 2019: 8
- FWCI
- 21.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Funders
- European Union in the Seventh Framework Programme (FP7-HEALTH-2012-INNOVATION, 304815)
- German Federal Ministry of Education and Research
- Danish Advanced Technology Foundation (005-2011-1)
- Bill and Melinda Gates Foundation (42387, OPP1055855)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- malaria in pregnancy, malaria vaccine, VAR2CSA, Plasmodium falciparum, placental sequestration, chondroitin sulfate A, Alhydrogel adjuvant, vaccine safety, immunogenicity, antibody binding inhibition, malaria-naive volunteers
- MeSH terms
- Adult, Aluminum Hydroxide, Chondroitin Sulfates, Double-Blind Method, Female, Humans, Injections, Intramuscular, Liposomes, Plasmodium falciparum, Pregnancy, Malaria Vaccines, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.